Testosterone replacement in elderly men

Geriatrics

Volumn 62, Issue 9, 2007, Pages 15-18

  Baum, Neil H ^a,b,c   Crespi, Candace A ^d  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Touro Infirmary   (United States)

^c East Jefferson General Hospital   (United States)

^d GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Cardiovascular disease; Erectile dysfunction; Hypoandrogenism; Hypogonadism; Impaired cognition; Osteoporosis; Testosterone deficiency

Indexed keywords

GONADORELIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; PROLACTIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

AGING; ALCOHOLISM; ANDROPAUSE; BONE DENSITY; BREAST CANCER; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; ERECTILE DYSFUNCTION; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; INCIDENCE; INSULIN SENSITIVITY; LIBIDO DISORDER; LIVER TOXICITY; MENOPAUSE; MORBID OBESITY; PATHOPHYSIOLOGY; PREVALENCE; PROSTATE CANCER; PROSTATECTOMY; REVIEW; SMOKING; SYMPTOM; TESTOSTERONE BLOOD LEVEL; TESTOSTERONE DEFICIENCY; TREATMENT CONTRAINDICATION;

AGED; ANDROGENS; ANDROPAUSE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOGONADISM; MALE; MIDDLE AGED; TESTOSTERONE;

EID: 34548750386     PISSN: 0016867X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Gray A, Feldman HA, McKinlay JB, et al. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 1991;73(5):1016-1025.
2. Stas SN, Anastasiadis AG, Fisch H, et al. Urologic aspects of andropause. Urology. 2003;61(2):261-266.
3. MacIndoe JH. The challenges of testosterone deficiency: uncovering the problem, evaluating the role of therapy. Postgrad Med. 2003;114(4):51-62.
4. The Endocrine Society. Summary from the Second Annual Andropause Consensus Meeting. Beverly Hills, Calif: Highwire Press; 2001:1-5.
5. Rhoden EL, Morgentaler A. Risks of testosterone replacement therapy and recommendations for monitoring. N Engl J Med. 2004;350(5):482-492.
6. Seftel A. Testosterone replacement therapy in the older male. Med Clin N Am. 2006;90(suppl 1):28-31.
7. McLaughlin SP, Shaban SF, Carson CC. Androgen deficiency in the aging male. In: Kirby RS, Carson CC III, Kirby MG, et al, eds. Men's Health. New York, NY: Taylor and Francis; 2004.
8. Bhasin S. Regulation and physiology of testosterone secretion. Med Clin N Am. 2006;90(suppl 1):8-13.
9. Heaton JP. Hormone treatments and preventive strategies in the aging male: whom and when to treat? Rev Urol. 2003;5(suppl 1):S16-S21.
10. Baum N. Androgen deficiency in the aging male. Clin Geriatr. 2006;14(8):22-24.
11. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients: 2002 update. Endocr Pract. 2002;8(6):440-456.
12. Zgliczynski S, Ossowski M, Slowinska-Szrendnicka J, et al. Effect of testosterone replacement therapy on lipids and lipoproteins in hypogonadal and elderly men. Atherosclerosis. 1996:121(1):35-43.
13. World Health Organization. Third International Consensus Consultation on Prostate Cancer. 2002; Paris, France.
14. Morales A, Lunenfeld B. Investigation, treatment and monitoring of late-onset hypogonadism in males: official recommendations of ISSAM. Aging Male. 2002;5(2):74-86.
15. Kaufman JM, Graydon RJ. Androgen replacement after curative radical prostatectomy for prostate cancer in hypogonadal men. J Urol. 2004;172(3):920-922.
16. Agarwal PK, Oefelein MG. Testosterone replacement therapy after primary treatment for prostate cancer. J Urol. 2005;173(2):533-536.
17. J Kaufman. A rational approach to androgen therapy for hypogonadal men with prostate cancer. Int J Impot Res. 2006;18(1):26-31.